AKTX

Akari Therapeutics, Plc

HealthcareBiotechnologyGBUSDPeers →Country macro →

$11.23

LiveJun 22, 2026

AI Brief

Market cap

$12.85M

52w range

3.02 – 49.60

P / E

—

EPS

—

Volume

204.55K

Revenue · FY

—

Overview Fundamentals Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Akari Therapeutics, Plc’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for AKTX.

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $1,200.00 (+10585.66%)

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+2.65%	-6.57%	-38.53%	+93.62%	+14.48%	-2.85%	-75.80%	-91.28%	-99.17%	-99.90%	-99.91%

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Aftermarket

Live

Jun 22, 11:07 PM

Last trade

$11.97

2 sh

Bid

$9.80

100 sh

Ask

$12.01

1 sh

Spread

$2.210

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.26%
Industrials
+1.00%
Basic Materials
+0.65%
Energy
+0.59%
Healthcare
+0.01%
Utilities
-0.07%
Financial Services
-0.24%
Communication Services
-0.55%
Technology
-0.80%
Consumer Cyclical
-0.85%
Consumer Defensive
-1.00%

Top industries (issuer's industry highlighted)

Biotechnology
+6.56%
Financial - Mortgages
-4.05%
Electrical Equipment & Parts
+3.88%
Staffing & Employment Services
-3.62%
Software - Services
-3.30%
Software - Infrastructure
-3.07%
Advertising Agencies
+2.92%
Apparel - Footwear & Accessories
-2.80%
Engineering & Construction
+2.80%
Financial - Conglomerates
+2.62%
Luxury Goods
+2.47%
Hardware, Equipment & Parts
+2.34%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for AKTX.

Peers

No peer list available for AKTX.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin